Acclarent Pays $18M For Off-Label Marketing Of Sinus Device

Mealey's (July 25, 2016, 1:33 PM EDT) -- BOSTON — With a criminal trial against two company executives just concluded, the U.S. attorney for the District of Massachusetts on July 22 revealed that medical device maker Acclarent Inc. paid $18 million to settle lawsuits that it caused false claims to be submitted to federal health care programs through the off-label marketing of its Stratus nasal device (United States of America, ex rel. Melayna Lokosky v. Acclarent, Inc., et al., No. 11-11217, United States of America, ex rel. WW. Young, III v. Acclarent, Inc., et...
To view the full article, register now.